Epidemiology and diagnostic and therapeutic management of febrile seizures in the Italian pediatric emergency departments: A prospective observational study

详细信息    查看全文

• 作者：Giovanna Vitaliti^a ; ^{giovitaliti@yahoo.it} ; Emanuele Castagno^b ; Fulvio Ricceri^c ; Antonio Urbino^b ; Alberto Verrotti Di Pianella^d ; Riccardo Lubrano^e ; Elisa Caramaschi^f ; Maurizio Prota^g ; Rita Maria Pulvirenti^h ; Patrizia Ajovalasitⁱ ; Giuseppe Signorile^j ; Carla Navone^k ; Maria Rosaria La Bianca^l ; Alberto Villani^m ; Giovanni Corselloⁿ ; Raffaele Falsaperla^a
• 关键词：Epidemiologic study ; Simple and complex febrile seizures ; Emergency department ; Pediatrics ; Italian population
• 刊名：Epilepsy Research
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：129
• 期：Complete
• 页码：79-85
• 全文大小：401 K
• 卷排序：129

文摘

To our knowledge this is the first study assessing prevalence and epidemiologic characteristics of FS in the Italian pediatric population. The results of our study are sometimes in line with current literature data, even if mostly highlighted some interesting topics of research on international level, evidencing a higher prevalence of CFSs in children younger than 12 months of age and opening a new research scenario on the involvement of the blood brain barrier vulnerability in children affected by FS under 12 months of age. Experimental studies, leaded in the 80s, showed that the Central Nervous System (CNS) homeostasis was constitutively altered in case of seizures lasting more than 30 min. In regards, literature data suggest to shorten the time of seizure duration, in order to reduce CNS risk factors. On the other hand, further studies showed that a single epileptic event usually resolve within 2–5 min, while those critical events lasting more than 10–15 min show a higher risk not to be spontaneously resolved. Therefore, the importance for an adequate diagnosis and prompt treatment of CFSs, above all in the youngest. In our study, most of the children experienced simple FS (71.65%). Among the 68 (25.37%) patients with complex FS, 11 were 6–12 month-old, accounting for 45.83% of all the infants with FS in the younger age group. No therapy has been administered at home in 76.12% patients; 23.51% of them received endorectal diazepam and only 1 patient received buccal midazolam. At arrival at ED, no therapy was necessary for 70.52% patients; 50.63% received endorectal diazepam and 17.72% an i.v. bolus of midazolam. Among patients who had not receive any therapy, 4.61% of children had seizures lasting more than 10 min. On a national level, our study showed the need of a diagnostic standardized work-up to improve the management of FS at ED, in line with an improvement of the cost/benefit ratio. Moreover further efforts should be done to innovate in the therapeutic field, achieving a better education on FS pre-hospitalization treatment and introducing the use of new drugs, such as oral midazolam, as standard CSF resolution therapy in Paediatric ED.